Mansurov, Aslan http://orcid.org/0000-0001-6574-9053
Ishihara, Jun http://orcid.org/0000-0002-9083-9859
Hosseinchi, Peyman http://orcid.org/0000-0002-5159-633X
Potin, Lambert http://orcid.org/0000-0002-6760-5560
Marchell, Tiffany M. http://orcid.org/0000-0002-9913-9664
Ishihara, Ako
Williford, John-Michael
Alpar, Aaron T. http://orcid.org/0000-0003-4669-4813
Raczy, Michal M.
Gray, Laura T. http://orcid.org/0000-0002-5958-4405
Swartz, Melody A. http://orcid.org/0000-0001-5484-1903
Hubbell, Jeffrey A. http://orcid.org/0000-0003-0276-5456
Article History
Received: 9 July 2019
Accepted: 12 March 2020
First Online: 13 April 2020
Competing interests
: J.I., A.I., M.A.S. and J.A.H. are inventors on U.S. Provisional Patent applications 62/638,520, 28/984,351 and 62/727,156. J.I., A.I., M.A.S. and J.A.H. are founders and shareholders in Arrow Immune Inc., which is developing the technology presented in this report, and M.A.S. and J.A.H. have leadership roles in that company. The other authors declare no competing interests.